Drug Information

Drug General Information
Drug ID
D08MON
Former ID
DNC013873
Drug Name
3-Benzyl-5-methoxy-7-methylchromen-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Formula
C18H16O3
Canonical SMILES
CC1=CC2=C(C=C(C(=O)O2)CC3=CC=CC=C3)C(=C1)OC
InChI
1S/C18H16O3/c1-12-8-16(20-2)15-11-14(18(19)21-17(15)9-12)10-13-6-4-3-5-7-13/h3-9,11H,10H2,1-2H3
InChIKey
AOPKGUPAQXHRKK-UHFFFAOYSA-N
PubChem Compound ID
16067266
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530009]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.